Mass.-based marijuana giant Curaleaf, which owns a Simsbury marijuana growing facility, said it has removed statements from its website and social media platforms identified as non-compliant by federal regulators.
In a statement Friday, the company responded to the U.S. Food and Drug Administration’s notice by removing statements claiming certain CBD products can treat certain diseases.
That included removing entirely the company’s hemp blog and all third-party links in it, the company said.
The company noted several products mentioned by the FDA were previously discontinued.
„Our industry needs, wants and appreciates the work the FDA is doing to ensure there is regulation and compliance in the CBD marketplace,” CEO Joseph Lusardi said in a statement.
Curaleaf was warned by the FDA earlier this week for claiming on its website some CBD products sold online can treat cancer, Alzheimer’s opioid withdrawal, pain and pet anxiety.
CBD — or cannabidiol — is the non-psychoactive chemical in cannabis or hemp some say can help treat some ailments. Its legal status remains unclear even after Congress legalized hemp last year.
Curaleaf is one of the largest marijuana operators in the U.S. and has a large presence in the Massachusetts.
The FDA warning this week came after a coalition of state attorneys general, including Connecticut’s William Tong, appealed to the agency to ensure CBD products are safe and marketed accurately.
Hartford Business Journal contributed to this report